14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
BHFAN vs BHFAM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Brighthouse Financial, Inc. Depositary shares each representing a 1/1,000th Interest in a Share of 4.625% Non-Cumulative Preferred Stock, Series D (BHFAM) captures the overall head-to-head institutional edge over Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) on higher Unified Composite conviction (33.6/100 SELL vs. 33.7/100 SELL) after splitting the core matrix 1–1 (led by composite factor balance), while BHFAN wins 1–0 across the 6-pillar growth and valuation breakdown. BHFAN trades at $9.18 (N/M Forward P/E, 18.4% operating margin) versus BHFAM at $8.53 (N/M Forward P/E, 18.4% operating margin).
Growth vs. Quality Trade-Off: BHFAM earns the overall head-to-head edge with a stronger Unified Composite Score (33.6/100 SELL vs. BHFAN 33.7/100 SELL) and 0.47β · 22% Vol risk profile, whereas BHFAN leads top-line expansion (-52.7% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Defensive Composite Rating Caution: Although BHFAM compares more favorably head-to-head, both BHFAN (33.7/100 SELL) and BHFAM (33.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: BHFAN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9); meanwhile BHFAM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHFAN vs BHFAM. Trailing 12-month operating profitability (BHFAN 18.4% vs BHFAM 18.4%) and valuation multiples (BHFAN N/M vs BHFAM N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance - Life value chain with N/A market capitalization and 18.4% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ BHFAN vs BHFAM Key Questions & Quantitative Answers
As of Nov 20, 2026, Brighthouse Financial, Inc. Depositary shares each representing a 1/1,000th Interest in a Share of 4.625% Non-Cumulative Preferred Stock, Series D (BHFAM) captures the overall head-to-head institutional edge over Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) on higher Unified Composite conviction (33.6/100 SELL vs. 33.7/100 SELL) after splitting the core matrix 1–1 (led by composite factor balance), while BHFAN wins 1–0 across the 6-pillar growth and valuation breakdown. BHFAN trades at $9.18 (N/M Forward P/E, 18.4% operating margin) versus BHFAM at $8.53 (N/M Forward P/E, 18.4% operating margin). Growth vs. Quality Trade-Off: BHFAM earns the overall head-to-head edge with a stronger Unified Composite Score (33.6/100 SELL vs. BHFAN 33.7/100 SELL) and 0.47β · 22% Vol risk profile, whereas BHFAN leads top-line expansion (-52.7% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although BHFAM compares more favorably head-to-head, both BHFAN (33.7/100 SELL) and BHFAM (33.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: BHFAN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9); meanwhile BHFAM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
BHFAN and BHFAM split Growth & Scale metrics: BHFAN posts -52.7% YoY revenue growth and -34.0% YoY earnings growth on $5.81B TTM revenue (16.5% gross margin, 18.4% operating margin), compared with BHFAM at -52.7% YoY revenue growth and -34.0% YoY earnings growth on $5.81B TTM revenue (16.5% gross margin, 18.4% operating margin). On trailing 12-month operating scale, BHFAN generates $5.81B in USD-normalized revenue versus $5.81B for BHFAM. In operating R&D and SG&A reinvestment, BHFAN deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BHFAM.
BHFAN and BHFAM trade at balanced relative valuation multiples. BHFAN trades at N/M Forward P/E, 0.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BHFAM trades at N/M Forward P/E, 0.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHFAN (11.9% ROE) versus BHFAM (11.9% ROE) capital efficiency.
In options market volatility and institutional positioning, BHFAN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.36β · 16% Vol realized risk). By comparison, BHFAM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.47β · 22% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) Research Suite
Brighthouse Financial, Inc. Depositary shares each representing a 1/1,000th Interest in a Share of 4.625% Non-Cumulative Preferred Stock, Series D (BHFAM) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.